796 results on '"Selek, Ugur"'
Search Results
402. Impact of Weight Change During the Course of Concurrent Chemoradiation Therapy on Outcomes in Stage IIIB Non-Small Cell Lung Cancer Patients: Retrospective Analysis of 425 Patients
403. Use of CT simulation for treatment of cervical cancer to assess the adequacy of lymph node coverage of conventional pelvic fields based on bony landmarks: In regard to Finlay et al. (Int J Radiat Oncol Biol Phys 2006;64:205–209)
404. In Reference to Treatment Outcome in Head and Neck Cancer with Distant Metastasis at Initial Diagnosis.
405. Peer Review in Radiation Oncology: Where Does the Middle East, North Africa, and Türkiye Region Stand?
406. Causes of Delays in Starting Postoperative Radiotherapy Among Head and Neck Cancer Patients.
407. Prognostic Value of Novel CARWL Score in Stage IIIC Non-Small-Cell Lung Cancer Patients Undergoing Concurrent Chemoradiotherapy.
408. Global Immune-Nutrition-Inflammation Index as a novel comprehensive biomarker in predicting the radiation-induced trismus rates in locally advanced nasopharyngeal carcinoma patients.
409. Pre-chemoradiotherapy high platelet counts predict jaw osteoradionecrosis in locally advanced nasopharyngeal carcinoma patients.
410. Comment on Survivin -31G/C polymorphism and disease fate in of oral squamous cell carcinomas.
411. Comment on "Management of 80 sinonasal undifferentiated carcinomas. Retrospective multicentre study of the French Network of Rare Head and Neck Cancers (REFCOR). https://doi.org/10.1016/j.ejso.2023.107108."
412. Implementation and Efficacy of a Large-Scale Radiation Oncology Case-Based Peer-Review Quality Program across a Multinational Cancer Network.
413. Tooth Extraction and Osteoradionecrosis.
414. Comment on Konishi et al.
415. Response to Deantoni et al.
416. Re: Minimum detectable change in occlusal load - Normative data for healthy and head and neck cancer populations.
417. Comment on: Radiotherapy and long-term sequelae in pediatric patients with parameningeal rhabdomyosarcoma: Results of two Cooperative Weichteilsarkom Studiengruppe (CWS) trials and one registry.
418. Comment on 'accelerated hypofractionated chemoradiation for locally advanced head and neck cancer during COVID-19 pandemic: A tertiary care experience'.
419. Recommended approaches for screening and early detection of lung cancer in the Middle East and Africa (MEA) region: a consensus statement.
420. Worth of pan-immune-inflammation value in trismus prediction after concurrent chemoradiotherapy for nasopharyngeal carcinomas.
421. Letter re: Reduced-dose radiotherapy for Epstein-Barr virus DNA selected staged III nasopharyngeal carcinoma: A single-arm, phase 2 trial.
422. Comment on: Long-term effects of chemotherapy and radiation received during early childhood on the developing dentition of pediatric cancer patients.
423. Comment on Prospective Study to Compare Efficacy of Conventional Chemoradiotherapy with Hypofractionated Chemoradiotherapy in Locally Advanced Carcinoma of Oropharynx.
424. Comment on "A systematic review and meta-analysis of osteoradionecrosis following proton therapy in patients with head and neck cancer".
425. Predictive potential of pan-immune-inflammation value / hemoglobin index as biomarker for osteoradionecrosis risk in locally advanced nasopharyngeal carcinomas.
426. The Use of Pre-Chemoradiotherapy Total Masseter Muscle Volume as a Novel Predictor of Radiation-Induced Trismus in Locally Advanced Nasopharyngeal Carcinoma Patients.
427. De-Escalation of Therapy for Prostate Cancer.
428. Toxicities and prognostic factors in elderly HPV-associated oropharyngeal cancer patients treated with radiotherapy or chemoradiotherapy.
429. Letter to the Editor: Local Treatment of Children Suffering From Parameningeal Rhabdomyosarcoma - A Retrospective Single-Center Study From China.
430. RE: Fibular free flap necrosis after mandibular reconstruction surgery with osteoradionecrosis: Establishment and verification of an early warning model.
431. High pre-chemoradiotherapy pan-immune-inflammation value levels predict worse outcomes in patients with stage IIIB/C non-small-cell lung cancer.
432. Predicting Teeth Extraction after Concurrent Chemoradiotherapy in Locally Advanced Nasopharyngeal Cancer Patients Using the Novel GLUCAR Index.
433. Comment on: Intensity Modulated Radiotherapy in Head and Neck Cancer: Initial Experience of the First Treated Cases from North-East India.
434. In Reference to Difficult Tracheal Intubation and Airway Outcomes After Radiation for Nasopharyngeal Carcinoma.
435. Comments on: Carcinoma buccal mucosa treated with definitive hypofractionated accelerated radiotherapy: a retrospective analysis of treatment outcomes.
436. Pretreatment Masseter Muscle Volume Predicts Survival in Locally Advanced Nasopharyngeal Carcinoma Patients Treated with Concurrent Chemoradiotherapy.
437. Comment on: Predictive value of health-related quality of life on radiotherapy-related toxicities in patients with head and neck cancer.
438. Initial neutrophil-to-lymphocyte ratio predicts radiation-induced trismus in parotid gland cancer.
439. Hemoglobin-to-platelet ratio in predicting the incidence of trismus after concurrent chemoradiotherapy.
440. Utility of pre-chemoradiotherapy Pan-Immune-Inflammation-Value for predicting the osteoradionecrosis rates in locally advanced nasopharyngeal cancers.
441. The Prognostic Value of the Novel Global Immune-Nutrition-Inflammation Index (GINI) in Stage IIIC Non-Small Cell Lung Cancer Patients Treated with Concurrent Chemoradiotherapy.
442. In reply to Mehanna H et al.
443. RE: What Risk Factors Are Associated With Poorer Quality of Life in Patients with Head and Neck Cancer?
444. In Reference to Amina et al (2022) Titled: 'Radiation Therapy Treatment Outcomes for Patients with Head and Neck Cancer: A Tertiary Care Centre Experience in a Tier Three Town' (doi: 10.1007/s12070-021-02810-7).
445. In reply to Cheng et al. (DOI: 10.1186/s13550-023-00965-8).
446. Valero's host index is useful in predicting radiation-induced trismus and osteoradionecrosis of the jaw risks in locally advanced nasopharyngeal carcinoma patients.
447. Letter to the Editor: Early detection of mandible osteoradionecrosis risk in a high comorbidity veteran population.
448. The predictive usefulness of the novel "combined hemoglobin-to-platelet ratio and maximum mouth opening index" on prevalence of radiation induced trismus in patients with nasopharyngeal cancer.
449. Letter to the Editor regarding "The influence of antibiotic administration on the outcomes of head-and-neck squamous cell carcinoma patients undergoing definitive (chemo)radiation" by Rühle et al.
450. Pre-chemoradiotherapy low hemoglobin levels indicate increased osteoradionecrosis risk in locally advanced nasopharyngeal cancer patients.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.